Semax is a synthetic heptapeptide derived from an adrenocorticotropic hormone fragment, evaluated in preclinical neurobiology for its effects on neurotrophic factor expression and cellular responses to oxidative stress. In laboratory settings, research formats—including solid matrices and lyophilized compounds—are studied to characterize peptide stability, enzymatic resistance, and central nervous system pathway signaling. PX1 Research supplies high-purity, USA-manufactured research compounds with lot-specific analytical documentation for qualified laboratory applications.
Semax is a synthetic heptapeptide derived from an adrenocorticotropic hormone fragment, evaluated in preclinical neurobiology for its effects on neurotrophic factor expression and cellular responses to oxidative stress. In laboratory settings, research formats—including solid matrices and lyophilized compounds—are studied to characterize peptide stability, enzymatic resistance, and central nervous system pathway signaling. PX1 Research supplies high-purity, USA-manufactured research compounds with lot-specific analytical documentation for qualified laboratory applications.
In scientific literature, Semax tablets represent solid oral or sublingual delivery formulations of the synthetic heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro). Derived from the N-terminal fragment of adrenocorticotropic hormone—specifically ACTH(4-10)—with an added C-terminal Pro-Gly-Pro tripeptide sequence, Semax is investigated for its potential neuroprotective and neurotrophic modulatory properties.
When evaluating the Semax research compound in experimental designs, researchers analyze how solid matrix administration compares to parenteral or intranasal administration regarding peptide degradation kinetics, hepatic first-pass metabolism, and blood-brain barrier penetration. These solid formulations are engineered primarily to evaluate enzymatic breakdown resistance provided by the C-terminal tripeptide extension in digestive and systemic environments.
Semax possesses the chemical structure L-methionyl-L-glutamyl-L-histidyl-L-phenylalanyl-L-prolyl-glycyl-L-proline. The native ACTH(4-10) sequence (Met-Glu-His-Phe) provides the core biological signaling motif, while the attached Pro-Gly-Pro tripeptide sequence significantly alters the molecule's pharmacokinetic profile. In vitro assays demonstrate that native ACTH fragments undergo rapid cleavage by circulating peptidases, exhibiting a half-life measured in minutes.
The introduction of the C-terminal Pro-Gly-Pro motif enhances structural resistance against carboxypeptidases and endopeptidases. In preclinical models, this structural modification prolongs biological stability in blood plasma and tissue homogenates. Researchers studying ACTH-derived analogs focus on how this increased enzymatic stability permits sustained signaling without inducing classical hormonal responses, such as corticosteroid secretion, due to the complete absence of the steroidogenic sequence found in full-length ACTH.
A central focus of preclinical investigation into Semax is its capacity to upregulate neurotrophic factors, particularly Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). Preclinical studies suggest that administration of Semax leads to a rapid increase in BDNF mRNA expression within the basal forebrain, hippocampus, and cerebral cortex of rodent models.
This elevation in BDNF transcript levels corresponds with downstream activation of Tropomyosin receptor kinase B (TrkB) receptor signaling cascades. Through the activation of the MAPK/ERK and PI3K/Akt pathways, research indicates that Semax-treated neural cultures exhibit altered synaptic plasticity, enhanced dendritic spine density, and resistance to apoptosis induced by excitotoxic glutamate exposure. Investigating these pathways provides critical insight into how neuroprotective peptides maintain cellular viability during stress events.
Preclinical models of focal cerebral ischemia have served as primary testbeds for evaluating the cytoprotective mechanisms of Semax. In rodent middle cerebral artery occlusion (MCAO) experiments, administration of Semax demonstrated a measurable reduction in ischemic lesion volume and associated neurological deficits compared to control groups.
Gene expression profiling of brain tissue following ischemic injury reveals that Semax modulates inflammatory cascades. Specifically, in vitro and animal studies report downregulation of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, alongside upregulation of vascular endothelial growth factor (VEGF) and its receptors. These molecular shifts promote microvascular preservation, suppress excessive lipid peroxidation, and maintain mitochondrial membrane potential under hypoxia.
In laboratory research settings, the choice between solid tablet formats and high-purity lyophilized powders depends entirely on the experimental model and required route of administration. Semax tablets are typically formulated with excipients designed to stabilize the peptide against stomach acid or facilitate transmucosal absorption in animal models.
However, for quantitative analytical assays, broad cell-culture studies, and precise dosing regimens, research laboratories overwhelmingly utilize pure lyophilized powder. Reconstituting pure Semax allows investigators to control molar concentrations exactly, eliminate confounding variables introduced by tablet binders or fillers, and ensure consistent delivery across automated high-throughput assays. Researchers exploring all research peptides typically select lyophilized vials when absolute chemical clarity is required.
Beyond neurotrophic activation, Semax influences central monoaminergic neurotransmitter systems. In vivo microdialysis studies in rodents show that Semax administration alters extracellular concentrations of dopamine and serotonin, as well as their primary metabolites (DOPAC, HVA, and 5-HIAA), within the striatum and prefrontal cortex.
Data suggest that Semax does not act as a direct agonist at classical monoamine receptors, but rather functions as a positive neuromodulator. It appears to enhance the release of dopamine under conditions of physical or environmental stress while stabilizing turnover rates. This dual action—combining neurotrophic support with monoamine modulation—explains the peptide's observed impact on learning, memory consolidation, and stress adaptation in animal behavior models.
When evaluating neuropeptides involved in central nervous system modulation, researchers frequently compare Semax to structurally or functionally related compounds within the same experimental paradigms. The table below highlights key parameters across prominent research candidates:
While Semax originates from an ACTH fragment focused on neurotrophic expression, Selank is a synthetic derivative of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) modified with the same C-terminal Pro-Gly-Pro sequence. Selank exhibits pronounced modulation of the GABAergic system and immune-related gene expression in preclinical models. In contrast, compounds such as Noopept operate through distinct dipeptide pathways targeting AMPA receptor activity. Comparing these mechanisms helps researchers select the precise molecular tool for their neurobiological inquiries.
Precision in peptide research requires absolute assurance of compound purity and identity. PX1 Research enforces strict quality control protocols for every batch of Semax synthesized. Analytical verification is conducted through independent, ISO 17025-accredited laboratories using dual-spectrum methodology.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) ensures that peptide purity meets or exceeds 99.0%, with clear baseline resolution separating the primary peak from potential truncated sequences or deletion peptides. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact monoisotopic mass. Furthermore, every lot undergoes rigorous Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly under <0.01 EU/mg, preventing confounding immune reactions in delicate cellular or tissue models. Visit our research library hub to examine sample analytical reports.
Proper handling of Semax is vital to prevent physical denaturation, enzymatic degradation, or loss of biological potency during experimentation. Lyophilized Semax should be stored upon receipt in a temperature-controlled freezer at -20°C or -80°C, isolated from moisture and light exposure.
For reconstitution, laboratories should use sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). The diluent should be introduced gently along the glass wall of the vial without aggressive vortexing, allowing the cake to dissolve naturally. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and maintained at 2°C to 8°C for short-term experimentation (less than 14 days) or -80°C for long-term storage.
Selecting a reliable supplier for research compounds is critical to ensuring experimental reproducibility and data integrity. PX1 Research provides USA-manufactured research peptides synthesized in cGMP-compliant facilities, eliminating the purity variances commonly associated with unverified imported materials.
Every product batch is issued with a transparent, lot-specific Certificate of Analysis (COA) detailing HPLC purity profiles, mass spectral confirmation, and endotoxin quantification. Laboratories seeking bulk quantities or specialized research supplies can request customized options through our wholesale account portal. PX1 Research ships directly from facilities in California and Arizona with same-day dispatch (M–F), ensuring your laboratory receives verified compounds without supply chain delays.
What is the structural difference between Semax and standard ACTH?
Semax consists only of the N-terminal 4-10 amino acid fragment of ACTH (Met-Glu-His-Phe) coupled to a C-terminal Pro-Gly-Pro tripeptide. It lacks the hormonal sequence required to stimulate adrenal corticosteroid release, eliminating endocrine activity while enhancing enzymatic stability.
Are Semax tablets suitable for quantitative laboratory assays?
While solid formats are studied to evaluate oral delivery parameters, pure lyophilized powder is preferred for precise laboratory assays. Reconstituted powders eliminate excipient variables, allowing exact molar concentrations in cell cultures or tissue models.
What analytical tests verify PX1 Research Semax purity?
Every lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity verification (>99.0%), Electrospray Ionization Mass Spectrometry (ESI-MS) for identity confirmation, and LAL testing to ensure endotoxin levels are under <0.01 EU/mg.
How does Semax influence BDNF signaling in preclinical models?
Preclinical studies show that Semax rapidly upregulates BDNF mRNA expression in hippocampal and cortical tissues, triggering TrkB receptor activation and downstream MAPK/ERK signaling pathways associated with neuronal survival and plasticity.
What solvent should be used to reconstitute lyophilized Semax for in vitro research?
Sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended. Avoid vigorous agitation during dissolving to protect the peptide's tertiary structural integrity.
How should reconstituted Semax solutions be stored in the lab?
Reconstituted solutions should be stored in single-use aliquots at 2°C to 8°C for up to 14 days, or frozen at -80°C for extended periods to prevent degradation and avoid repeated freeze-thaw cycles.
What are the key functional differences between Semax and Selank?
Semax is an ACTH(4-10) analog focused primarily on neurotrophic upregulation (BDNF/NGF) and ischemic protection. Selank is a tuftsin derivative that primarily targets GABAergic neuromodulation and immune-related signaling.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in cGMP-compliant facilities in the United States and shipped directly from fulfillment centers located in California and Arizona with same-day shipping on weekdays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.